On the contrary, miR-885-3p could act as a tumor suppressor both in colon cancer by disrupting angiogenesis via targeting BMPR1A and blocking BMP/Smad/Id1 signaling35 and in breast cancer by targeting immunoregulatory protein B7-H337. Here, BMPR1A is linked to malignant colon neoplasm.